Related Experiment Video
Updated: May 28, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Basic clinical and laboratory features of filoviral hemorrhagic fever
Mark G Kortepeter1, Daniel G Bausch, Mike Bray
1Department of Preventive Medicine, Infectious Disease Clinical Research Program, Uniformed Services University of Health Sciences, Bethesda, Maryland 20814-5119, USA. mkortepeter@idcrp.org
Abstract:
The filoviruses Marburg and Ebola cause severe hemorrhagic fever (HF) in humans. Beginning with the 1967 Marburg outbreak, 30 epidemics, isolated cases, and accidental laboratory infections have been described in the medical literature. We reviewed those reports to determine the basic clinical and laboratory features of filoviral HF. The most detailed information was found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak of Ebola Sudan HF in Uganda, reports of epidemics in central Africa provided little controlled or objective clinical data. Other than the case fatality rate, there were no clear differences in the features of the various filovirus infections. This compilation will be of value to medical workers responding to epidemics and to investigators attempting to develop animal models of filoviral HF. By identifying key unanswered questions and gaps in clinical data, it will help guide clinical research in future outbreaks.
Insights
Filoviruses like Marburg and Ebola cause severe hemorrhagic fever (HF). A review of outbreaks found limited clinical data, with no clear differences between filovirus infections except fatality rates.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Filoviruses, including Marburg and Ebola viruses, are known to cause severe hemorrhagic fever (HF) in humans.
- Since the first documented outbreak in 1967, numerous epidemics, individual cases, and laboratory-acquired infections have been reported globally.
Purpose of the Study:
- To review and synthesize existing medical literature on filoviral hemorrhagic fevers.
- To determine the fundamental clinical and laboratory characteristics of filoviral HF based on reported cases and outbreaks.
Main Methods:
- A comprehensive review of published medical literature detailing filovirus outbreaks and infections.
- Analysis of clinical and laboratory data from reported cases, with a focus on information from industrialized countries and specific African outbreaks.
Main Results:
- Detailed clinical and laboratory data were more readily available from patients treated in industrialized nations.
- Limited controlled or objective clinical data were found in reports from central African epidemics, with the exception of the 2000 Ebola Sudan outbreak in Uganda.
- No significant differences in clinical features were observed among various filovirus infections, apart from case fatality rates.
Conclusions:
- The compilation of clinical and laboratory features is valuable for healthcare professionals responding to filovirus epidemics.
- This review identifies critical gaps in clinical data, guiding future research and the development of animal models for filoviral hemorrhagic fevers.
Related Concept Videos
Yellow Fever
Hemorrhagic Stroke ll: Pathophysiology
Coronavirus
Viral Hepatitis I: Introduction
Hemorrhagic Stroke l: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis

